These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8883231

  • 1. Acute and anticipatory emesis in breast cancer patients.
    Fernández-Marcos A, Martín M, Sanchez JJ, Rodriguez-Lescure A, Casado A, López Martin JA, Diaz-Rubio E.
    Support Care Cancer; 1996 Sep; 4(5):370-7. PubMed ID: 8883231
    [Abstract] [Full Text] [Related]

  • 2. [Incidence of emesis in outpatients on chemotherapy for breast cancer and the clinical efficacy of ondansetron hydrochloride tablets].
    Ishida T, Kusaba T, Hayakawa H.
    Gan To Kagaku Ryoho; 2002 May; 29(5):723-8. PubMed ID: 12040676
    [Abstract] [Full Text] [Related]

  • 3. High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer.
    Bosnjak SM, Nesković-Konstantinović ZB, Radulović SS, Susnjar S, Mitrovi LB.
    J Chemother; 2000 Oct; 12(5):446-53. PubMed ID: 11128567
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings.
    Hickok JT, Roscoe JA, Morrow GR, Stern RM, Yang B, Flynn PJ, Hynes HE, Kirshner JJ, Rosenbluth RJ.
    Cancer; 1999 Jul 01; 86(1):64-71. PubMed ID: 10391565
    [Abstract] [Full Text] [Related]

  • 6. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA, Lembersky B, Kaywin P, Kalman L, Yocom K, Friedman C.
    Cancer J Sci Am; 1998 Jul 01; 4(1):52-8. PubMed ID: 9467047
    [Abstract] [Full Text] [Related]

  • 7. Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting.
    Bosnjak SM, Neskovic-Konstantinovic ZB, Jovanovic-Micic DJ, Mitrovic LB, Radulovic SS.
    J Chemother; 1996 Aug 01; 8(4):315-8. PubMed ID: 8873840
    [Abstract] [Full Text] [Related]

  • 8. Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient.
    Campora E, Oliva C, Mammoliti S, Cetto GL, Fosser V, Marangolo M, Rosso R.
    Breast Cancer Res Treat; 1991 Oct 01; 19(2):129-32. PubMed ID: 1836746
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens.
    Barrenetxea G, Schneider J, Centeno MM, Romero H, de la Rica M, Rodríguez-Escudero FJ.
    Cancer Chemother Pharmacol; 1996 Oct 01; 38(5):471-5. PubMed ID: 8765442
    [Abstract] [Full Text] [Related]

  • 10. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F, Mohri H, Motomura S, Fukawa H, Tanabe J, Koharasawa H, Kanamori H, Hashimoto Y, Harano H, Sakai R, Tomita N, Fujimaki K, Takemura S, Hattori M.
    Gan To Kagaku Ryoho; 2002 Feb 01; 29(2):273-9. PubMed ID: 11865634
    [Abstract] [Full Text] [Related]

  • 11. Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
    Campora E, Giudici S, Merlini L, Rubagotti A, Rosso R.
    Am J Clin Oncol; 1994 Dec 01; 17(6):522-6. PubMed ID: 7977174
    [Abstract] [Full Text] [Related]

  • 12. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J, Chevallier B, Metz R, Fargeot P, Pujade-Lauraine E, Spielmann M, Tubiana-Hulin M, Paes D, Bons J.
    J Clin Oncol; 1990 Jun 01; 8(6):1063-9. PubMed ID: 2140854
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of anticipatory nausea and vomiting in breast cancer patients undergoing highly emetogenic chemotherapy.
    Alves RB, Rebouças CV, Yamada AMTD, Cruz FJSM.
    Rev Assoc Med Bras (1992); 2024 Jun 01; 70(4):e20230937. PubMed ID: 38716933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
    Levitt M, Warr D, Yelle L, Rayner HL, Lofters WS, Perrault DJ, Wilson KS, Latreille J, Potvin M, Warner E.
    N Engl J Med; 1993 Apr 15; 328(15):1081-4. PubMed ID: 8455665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice--a longitudinal analysis.
    Chan A, Kim HK, Hsieh RK, Yu S, de Lima Lopes G, Su WC, Baños A, Bhatia S, Burke TA, Keefe DM.
    Support Care Cancer; 2015 Jan 15; 23(1):283-91. PubMed ID: 25112561
    [Abstract] [Full Text] [Related]

  • 18. [Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy].
    Zhou J, Xu B, Zhou A.
    Zhonghua Zhong Liu Za Zhi; 1997 Nov 15; 19(6):460-2. PubMed ID: 10920884
    [Abstract] [Full Text] [Related]

  • 19. [Effect of ondansetron hydrochloride injection and tablet against nausea and vomiting in lung cancer patients receiving carboplatin].
    Miyamoto Y, Yagi K, Teramachi M, Oomasa M, Tomiyama K.
    Gan To Kagaku Ryoho; 1999 Jan 15; 26(1):125-30. PubMed ID: 9987508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.